Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Shares Outstanding (Weighted Average): 2022-2025

Historic Shares Outstanding (Weighted Average) for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $21.0 million.

  • Praxis Precision Medicines' Shares Outstanding (Weighted Average) rose 18.52% to $21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 18.52%. This contributed to the annual value of $18.6 million for FY2024, which is 117.48% up from last year.
  • As of Q3 2025, Praxis Precision Medicines' Shares Outstanding (Weighted Average) stood at $21.0 million, which was up 3.32% from $20.4 million recorded in Q2 2025.
  • Praxis Precision Medicines' Shares Outstanding (Weighted Average)'s 5-year high stood at $21.0 million during Q3 2025, with a 5-year trough of $3.0 million in Q1 2022.
  • In the last 3 years, Praxis Precision Medicines' Shares Outstanding (Weighted Average) had a median value of $17.1 million in 2024 and averaged $13.9 million.
  • Data for Praxis Precision Medicines' Shares Outstanding (Weighted Average) shows a peak YoY spiked of 313.23% (in 2024) over the last 5 years.
  • Over the past 4 years, Praxis Precision Medicines' Shares Outstanding (Weighted Average) (Quarterly) stood at $3.1 million in 2022, then skyrocketed by 172.82% to $8.6 million in 2023, then spiked by 117.48% to $18.6 million in 2024, then grew by 18.52% to $21.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $21.0 million for Q3 2025, versus $20.4 million for Q2 2025 and $20.2 million for Q1 2025.